VR avatar therapy for psychosis: linking thinking, self-awareness, and social cognition
Official title: Evaluation of Cognitive, Metacognitive, Social Cognition and Trauma Related-Variables in Patients With Psychosis Receiving VR-Based Avatar Therapy
Run by Fundació Sant Joan de Déu · NCT07091344 · Data updated 2026-11-12
This project will test whether cognitive, metacognitive, and social-cognition factors relate to how well VR-based avatar therapy helps people with schizophrenia who have persistent auditory hallucinations.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Fundació Sant Joan de Déu Academic / other |
| Locations | 1 site (Barcelona, Catalonia) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | September 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | August 29, 2025 |
| Trial ID | NCT07091344 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with a DSM-5 schizophrenia-spectrum diagnosis, persistent auditory hallucinations despite treatment, stable medication for at least four weeks, fluent in Spanish, and able to attend in-person VR sessions are ideal candidates.
✕Probably not a fit
People who cannot tolerate VR, have severe visual or neurological impairments, active substance abuse, intellectual disability, current suicidal risk, or who cannot identify a dominant voice for the avatar may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants with schizophrenia and ongoing auditory hallucinations will receive seven individual VR-based avatar therapy sessions delivered over a 12-week intervention period. Researchers will measure neurocognition, metacognition, emotion recognition, attributional style, theory of mind, and social perception using validated tools at screening, baseline, during therapy, and at a post-therapy follow-up. Childhood trauma will also be measured to explore its role as a predisposing factor. The goal is to identify which cognitive and metacognitive profiles predict better or worse therapy outcomes to inform more personalized approaches.
Why it matters
Potential benefit: If successful, the study could help tailor VR avatar therapy to individuals by identifying cognitive or metacognitive traits linked to better outcomes.
How similar studies have gone: Previous avatar-based VR interventions for auditory hallucinations have shown promising results, but combining them with detailed cognitive and metacognitive profiling is a relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
\*\*Inclusion Criteria:\*\* * Adults aged 18 years or older. * Diagnosis of schizophrenia spectrum disorder according to DSM-5 criteria. * Experience of persistent auditory hallucinations for at least 3 months (PANSS hallucination score ≥ 3). * Stable medication dosage for at least 4 weeks prior to recruitment. * Fluent in the spoken language of the study site (Spanish). * Able to provide informed consent. * Regular psychiatric follow-up care. \*\*Exclusion Criteria:\*\* * Inability to identify a dominant voice for Avatar Therapy intervention. * Intellectual disability based on medical history. * Active substance abuse. * Central nervous system injury or neurological disorders affecting cognitive performance. * Severe visual impairment that precludes the use of VR technology. * Aversion to virtual reality or prior experience of simulator sickness. * Current suicidal ideation or risk. * Lack of cooperation or inability to comply with study procedures.
Where it's running
-
Fundació Sant Joan de Déu - Unitat de Recerca del Parc Sanitari Sant Joan de Déu
Barcelona, Catalonia, Spain Recruiting
Study contacts
- Study coordinator: Susana Ochoa, PhD
- Email: susana.ochoa@sjd.es
- Phone: +34936406350
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transition Support for First-Episode Psychosis
A team-based program helps people experiencing their first psychotic episode move from hospital to outpatient care to see if they stay engaged and feel better.
-
SEEG-guided DBS for Schizophrenia
This study tests whether SEEG-guided deep brain stimulation can help people with treatment-resistant schizophrenia see if symptoms improve.
-
Using an epigenetic drug to boost virtual reality cognitive training for middle-aged and older adults with depression or bipolar disorder
This trial will test whether daily sodium butyrate combined with three weeks of virtual reality cognitive training improves thinking skills in symptomatically stable adults aged 40–75 with depression or bipolar disorder.
-
Medical and psychiatric profiling of adults admitted to general adult psychiatry wards
This project will collect questionnaires, rating scales, and case-note information from adults admitted to general adult psychiatry wards to see what their physical and mental health profiles look like.
-
iTEST: a blended mobile program to improve introspective accuracy (accurate self-judgment of abilities)
This trial tests whether iTEST — daily mobile cognitive training plus coaching that focuses on accurate self-judgment — helps adults with schizophrenia-spectrum or other psychotic disorders improve community functioning.
-
Rhythmic, vocal and body-based musical training to support thinking and social skills in schizophrenia
This trial tests whether a 6-month group musical program using rhythm, singing and movement can help adults with schizophrenia improve attention and negative symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.